acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet
- RxCUI
- 1049635
- RxNorm name
- acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet
- Display name
- Acetaminophen/oxyCODONE (Oral Pill)
- Full name
- acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet
- Term type
- SCD
- Status
- Active
- Strength
- 325-2.5 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-10-17 23:44:05
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 012011
- Active start
- 012011
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| acetaminophen | 325 MG / 1 EACH | acetaminophen | acetaminophen |
| oxycodone hydrochloride | 2.5 MG / 1 EACH | oxycodone | oxycodone hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| acetaminophen | 161 |
| oxycodone | 7804 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | acetaminophen 325 MG / oxyCODONE hydrochloride 2.5 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet | 1 | NAMES |
| RxNorm Synonym | APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 8 linked values | 8 | CODES |
| RxCUI | 1049635 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 10702-184-01 | 10702-184 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | KVK-Tech, Inc. | ANDA210644 |
| 10702-184-10 | 10702-184 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | KVK-Tech, Inc. | ANDA210644 |
| 10702-184-50 | 10702-184 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | KVK-Tech, Inc. | ANDA210644 |
| 13107-043-01 | 13107-043 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | Aurolife Pharma, LLC | ANDA201972 |
| 13107-043-05 | 13107-043 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | Aurolife Pharma, LLC | ANDA201972 |
| 13107-043-30 | 13107-043 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | Aurolife Pharma, LLC | ANDA201972 |
| 13107-043-99 | 13107-043 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | Aurolife Pharma, LLC | ANDA201972 |
| 31722-191-01 | 31722-191 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | Camber Pharmaceuticals, Inc. | ANDA207419 |
| 31722-191-05 | 31722-191 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | Camber Pharmaceuticals, Inc. | ANDA207419 |
| 31722-948-01 | 31722-948 | OXYCODONE AND ACETAMINOPHEN Oxycodone and Acetaminophen | Camber Pharmaceuticals, Inc. | ANDA207419 |
| 31722-948-05 | 31722-948 | OXYCODONE AND ACETAMINOPHEN Oxycodone and Acetaminophen | Camber Pharmaceuticals, Inc. | ANDA207419 |
| 70010-667-01 | 70010-667 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | Granules Pharmaceuticals Inc. | ANDA211708 |
| 70010-667-05 | 70010-667 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | Granules Pharmaceuticals Inc. | ANDA211708 |
| 72865-113-01 | 72865-113 | OXYCODONE AND ACETAMINOPHEN Oxycodone and Acetaminophen | XLCare Pharmaceuticals, Inc. | ANDA207419 |
| 72865-113-05 | 72865-113 | OXYCODONE AND ACETAMINOPHEN Oxycodone and Acetaminophen | XLCare Pharmaceuticals, Inc. | ANDA207419 |
| 76420-320-01 | 76420-320 | OXYCODONE AND ACETAMINOPHEN Oxycodone and Acetaminophen | Asclemed USA, Inc. | ANDA207419 |
| 76420-320-05 | 76420-320 | OXYCODONE AND ACETAMINOPHEN Oxycodone and Acetaminophen | Asclemed USA, Inc. | ANDA207419 |
| 76420-320-30 | 76420-320 | OXYCODONE AND ACETAMINOPHEN Oxycodone and Acetaminophen | Asclemed USA, Inc. | ANDA207419 |
| 76420-320-60 | 76420-320 | OXYCODONE AND ACETAMINOPHEN Oxycodone and Acetaminophen | Asclemed USA, Inc. | ANDA207419 |
| 76420-320-90 | 76420-320 | OXYCODONE AND ACETAMINOPHEN Oxycodone and Acetaminophen | Asclemed USA, Inc. | ANDA207419 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA210644 | 10702-184 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | ANDA | KVK-Tech, Inc. |
| ANDA201972 | 13107-043 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | ANDA | Aurolife Pharma, LLC |
| ANDA207419 | 31722-191 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | ANDA | Camber Pharmaceuticals, Inc. |
| ANDA211708 | 70010-667 | Oxycodone and Acetaminophen Oxycodone and Acetaminophen | ANDA | Granules Pharmaceuticals Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 4dd36cf5-8f73-404a-8b1d-3bd53bd90c25 | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [SCD] · APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [SY] | 3 | 62 | PERCOCET ® (Oxycodone and Acetaminophen Tablets, USP) CII Rx only Revised: December 2025 | 20260106 |
| 944d3e60-7eee-11de-a413-0002a5d5c51b | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [SCD] · APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [SY] | 3 | 55 | ENDOCET ® Oxycodone and Acetaminophen Tablets, USP CII Rx only Revised: December 2025 | 20251201 |
| 69df20d9-b1d5-47dc-9ff0-29987284f8c7 | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [SCD] · APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [SY] | 3 | 23 | Oxycodone and Acetaminophen Tablets, USP CII | 20251223 |
| f9cf218c-af5e-4249-aa3b-a8555ed02278 | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [SCD] · APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [SY] | 3 | 21 | Oxycodone and Acetaminophen Tablets, USP CII Rx only Rev.: 10/2025 | 20260504 |
| cc966d57-7cdc-4de3-bbcf-718e2fce9cb7 | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [SCD] · APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [SY] | 3 | 18 | Oxycodone and Acetaminophen Tablets USP CII Rx Only | 20251028 |
| 42777191-0454-4ccb-8fc3-8b18b0ee43f7 | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [SCD] · APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [SY] | 3 | 10 | Oxycodone and Acetaminophen Tablets, USP CII Rx only | 20250805 |
| 916ff456-a27e-49dc-a312-274126a8c30c | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [SCD] · APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [SY] | 3 | 8 | Oxycodone and Acetaminophen Tablets, USP CII Rx only | 20240229 |
| c50617ea-66b6-43be-b579-b9a3836b73a2 | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [SCD] · APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [SY] | 3 | 8 | Oxycodone and Acetaminophen Tablets, USP CII Revised: August 2020 | 20200818 |
| 7f3c6dd7-6bc8-450e-aded-997f9cf63a8f | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [SCD] · APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [SY] | 3 | 4 | Oxycodone and Acetaminophen Tablets, USP CII Rx only | 20240212 |
| 2a49ee34-6f1d-4ed3-8daa-343723d2a2be | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [SCD] · APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [SY] | 3 | 2 | Oxycodone and Acetaminophen Tablets, USP CII Rx Only | 20180220 |
| 71c7a627-6ed9-4f49-8cdc-b3228c021e64 | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet [PSN] · acetaminophen 325 MG / oxycodone hydrochloride 2.5 MG Oral Tablet [SCD] · APAP 325 MG / Oxycodone Hydrochloride 2.5 MG Oral Tablet [SY] | 3 | 1 | Oxycodone and Acetaminophen Tablets, USP CII Rx only | 20250415 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| cc966d57-7cdc-4de3-bbcf-718e2fce9cb7 | Oxycodone and Acetaminophen Tablets USP CII Rx Only | Granules Pharmaceuticals Inc. | 20261008 |
| 4dd36cf5-8f73-404a-8b1d-3bd53bd90c25 | PERCOCET ® (Oxycodone and Acetaminophen Tablets, USP) CII Rx only Revised: August 2026 | SpecGx LLC | 20261002 |
| 4dd36cf5-8f73-404a-8b1d-3bd53bd90c25 | PERCOCET ® (Oxycodone and Acetaminophen Tablets, USP) CII Rx only Revised: August 2026 | SpecGx LLC | 20260923 |
| 4dd36cf5-8f73-404a-8b1d-3bd53bd90c25 | PERCOCET ® (Oxycodone and Acetaminophen Tablets, USP) CII Rx only Revised: December 2025 | SpecGx LLC | 20260728 |
| 4dd36cf5-8f73-404a-8b1d-3bd53bd90c25 | PERCOCET ® (Oxycodone and Acetaminophen Tablets, USP) CII Rx only Revised: December 2025 | Endo USA, Inc. | 20260728 |
| f9cf218c-af5e-4249-aa3b-a8555ed02278 | Oxycodone and Acetaminophen Tablets, USP CII Rx only Rev.: 10/2025 | KVK-Tech, Inc. | ABHAI, LLC. | 20260504 |
| f9cf218c-af5e-4249-aa3b-a8555ed02278 | Oxycodone and Acetaminophen Tablets, USP CII Rx only Rev.: 10/2025 | KVK-Tech, Inc. | ABHAI, LLC. | 20260202 |
| 4dd36cf5-8f73-404a-8b1d-3bd53bd90c25 | PERCOCET ® (Oxycodone and Acetaminophen Tablets, USP) CII Rx only Revised: December 2025 | Endo USA, Inc. | 20260106 |
| 69df20d9-b1d5-47dc-9ff0-29987284f8c7 | Oxycodone and Acetaminophen Tablets, USP CII | Aurolife Pharma, LLC | 20251223 |
| 69df20d9-b1d5-47dc-9ff0-29987284f8c7 | Oxycodone and Acetaminophen Tablets, USP CII | Aurolife Pharma, LLC | 20251211 |
| cc966d57-7cdc-4de3-bbcf-718e2fce9cb7 | Oxycodone and Acetaminophen Tablets USP CII Rx Only | Granules Pharmaceuticals Inc. | 20251028 |
| 69df20d9-b1d5-47dc-9ff0-29987284f8c7 | Oxycodone and Acetaminophen Tablets, USP CII | Aurolife Pharma, LLC | 20250912 |
| cc966d57-7cdc-4de3-bbcf-718e2fce9cb7 | Oxycodone and Acetaminophen Tablets USP CII Rx Only | Granules Pharmaceuticals Inc. | 20250807 |
| 42777191-0454-4ccb-8fc3-8b18b0ee43f7 | Oxycodone and Acetaminophen Tablets, USP CII Rx only | Camber Pharmaceuticals, Inc. | Ascent Pharmaceuticals, Inc. | 20250805 |
| 71c7a627-6ed9-4f49-8cdc-b3228c021e64 | Oxycodone and Acetaminophen Tablets, USP CII Rx only | Asclemed USA, Inc. | ASCLEMED USA INC. DBA ENOVACHEM | 20250415 |
| 916ff456-a27e-49dc-a312-274126a8c30c | Oxycodone and Acetaminophen Tablets, USP CII Rx only | Lupin Pharmaceuticals,Inc. | Novel Laboratories, Inc. | 20240229 |
| 7f3c6dd7-6bc8-450e-aded-997f9cf63a8f | Oxycodone and Acetaminophen Tablets, USP CII Rx only | XLCare Pharmaceuticals, Inc. | Ascent Pharmaceuticals, Inc. | 20240212 |
| c50617ea-66b6-43be-b579-b9a3836b73a2 | Oxycodone and Acetaminophen Tablets, USP CII Revised: August 2020 | Zydus Pharmaceuticals (USA) Inc. | Nesher Pharmaceuticals (USA) LLC | 20200818 |
| 6eda7c38-6193-4005-9476-fe0137c36098 | Oxycodone and Acetaminophen Tablets, USP | Actavis Pharma, Inc. | 20190830 |
| cecec8f6-1033-4857-84e7-a98295ee364e | Oxycodone and Acetaminophen Tablets, USP 2.5 mg/325 mg CII Rx only Revised: AUGUST 2019 | Par Pharmaceutical, Inc. | 20190821 |
| 2a49ee34-6f1d-4ed3-8daa-343723d2a2be | Oxycodone and Acetaminophen Tablets, USP CII Rx Only | Camber Pharmaceuticals, Inc. | Ascent Pharmaceuticals, Inc. | 20180220 |
| 8c830a74-87bb-4c75-ae77-2a25e2249d28 | National Council for Prescription Drug Programs | 20120724 | |
| 3d1422bf-a3f6-4831-80b8-35d80516cdc5 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N02BE | Anilides | ATC1-4 | acetaminophen | |
| ATC | N02AA | Natural opium alkaloids | ATC1-4 | oxycodone | |
| FDASPL | N0000175690 | Opioid Agonist | EPC | has_epc | oxycodone |
| FDASPL | N0000175684 | Full Opioid Agonists | MOA | has_moa | oxycodone |
| MEDRT | D000082 | Acetaminophen | CHEM | has_ingredient | acetaminophen |
| MEDRT | D010098 | Oxycodone | CHEM | has_ingredient | oxycodone |
| MEDRT | D010098 | Oxycodone | CHEM | has_ingredient | oxycodone hydrochloride |
| MEDRT | D001249 | Asthma | DISEASE | ci_with | oxycodone hydrochloride |
| MEDRT | D001249 | Asthma | DISEASE | ci_with | oxycodone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | oxycodone hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | oxycodone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | acetaminophen |
| MEDRT | D005334 | Fever | DISEASE | may_prevent | acetaminophen |
| MEDRT | D005334 | Fever | DISEASE | may_treat | acetaminophen |
| MEDRT | D005955 | Glucosephosphate Dehydrogenase Deficiency | DISEASE | ci_with | acetaminophen |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | oxycodone hydrochloride |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | oxycodone |
| MEDRT | D007418 | Intestinal Pseudo-Obstruction | DISEASE | ci_with | oxycodone |
| MEDRT | D007418 | Intestinal Pseudo-Obstruction | DISEASE | ci_with | oxycodone hydrochloride |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_treat | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | acetaminophen |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | oxycodone hydrochloride |
| MEDRT | D010149 | Postoperative Pain | DISEASE | may_treat | oxycodone |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | oxycodone |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | oxycodone hydrochloride |
| MEDRT | D012131 | Respiratory Insufficiency | DISEASE | ci_with | oxycodone hydrochloride |
| MEDRT | D012131 | Respiratory Insufficiency | DISEASE | ci_with | oxycodone |
| MEDRT | N0000175684 | Full Opioid Agonists | MOA | has_moa | oxycodone hydrochloride |
| MEDRT | N0000175684 | Full Opioid Agonists | MOA | has_moa | oxycodone |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | acetaminophen |
| MEDRT | N0000175439 | Analgesia | PE | has_pe | oxycodone hydrochloride |
| MEDRT | N0000175439 | Analgesia | PE | has_pe | oxycodone |
| MEDRT | N0000175724 | Central Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000008635 | Decreased GI Motility | PE | has_pe | oxycodone |
| MEDRT | N0000008635 | Decreased GI Motility | PE | has_pe | oxycodone hydrochloride |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | oxycodone |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | oxycodone hydrochloride |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | oxycodone |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | oxycodone hydrochloride |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | acetaminophen |
| MEDRT | N0000009072 | Hypothalamic Endocrine Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000009353 | Increased Histamine Production | PE | has_pe | oxycodone hydrochloride |
| MEDRT | N0000009353 | Increased Histamine Production | PE | has_pe | oxycodone |
| MEDRT | N0000175725 | Peripheral Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | acetaminophen |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | acetaminophen |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 325 MG / 2.5 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 2 |
| CODES | ANDA | ANDA201972 |
| CODES | ANDA | ANDA204407 |
| CODES | ANDA | ANDA207419 |
| CODES | ANDA | ANDA210644 |
| CODES | ANDA | ANDA211708 |
| CODES | SNOMEDCT | 426352005 |
| CODES | VUID | 4014655 |
| NAMES | Prescribable Synonym | oxyCODONE HCl 2.5 MG / acetaminophen 325 MG Oral Tablet |
| NAMES | Tallman Synonym | acetaminophen 325 MG / oxyCODONE hydrochloride 2.5 MG Oral Tablet |
| NAMES | Tallman Synonym | APAP 325 MG / oxyCODONE Hydrochloride 2.5 MG Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | US Edition of SNOMED_CT |
| SOURCES | Source | Veterans Health Administration National Drug File |